MENU

Fox Chase Cancer Center to Participate in Virtual PurpleStride Philadelphia 2020

October 26, 2020

The Fox Chase Cancer Center team gathered at the 2019 PurpleStride event aimed at raising money for pancreatic cancer research and patient services.The Fox Chase Cancer Center team gathered at the 2019 PurpleStride event aimed at raising money for pancreatic cancer research and patient services.

PHILADELPHIA (October 26, 2020)— Fox Chase Cancer Center is proud to support the Pancreatic Cancer Action Network (PanCAN) for PurpleStride Philadelphia 2020. Fox Chase will participate virtually with pancreatic cancer survivors, their loved ones, caregivers, and researchers on Saturday, November 7, 2020, to raise money for pancreatic cancer research and patient services.

The event is being held virtually for the safety of participants in light of the global pandemic. Through a fundraising page, PurpleStride participants can take part individually or with a team to garner donations.

Sanjay S. Reddy, MD, FACS, associate professor in the Department of Surgical Oncology at Fox Chase, is this year’s team leader and honorary event co-chair. The clinicians, researchers, and staff on the Fox Chase team are affiliated with the center’s Marvin and Concetta Greenberg Pancreatic Cancer Institute.

“The true importance of the event is that it brings together many high-volume pancreatic cancer centers and offers opportunities for collaborative efforts,” said Reddy. “Through PanCAN, support through advocacy remains one of the most important goals of the foundation. This event gives a voice to a silent disease and by raising awareness allows us to obtain the much-needed funding to further our scientific endeavors to beat this disease.”

PurpleStride is PanCAN’s signature walk program, which raised approximately $14.9 million in 2018. This year, they aim to reach a $10 million goal, which will aid in PanCAN’s mission to advance research and create hope for families facing this deadly disease.

Although the five-year survival rate for pancreatic cancer was 6% in 2014, it has steadily increased to 10%, an increase due in many parts to the grassroots efforts by advocacy groups like PanCAN and the partnerships it builds within the health community.

For more information about Philadelphia PurpleStride 2020, to join the Fox Chase team, or to donate visit http://www.purplestride.org/philadelphia.

      

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase